Additional file 5: of Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease

Table S4. Mixed-Model Analyses for Neuropsychiatric Inventory Total Score. (DOCX 19 kb)